We are thrilled to announce a new partnership between the Foundation for Peripheral Neuropathy (FPN) and GlaxoSmithKline (GSK) as a 2024 Research Impact Partner. This collaboration, with GSK’s generous support, marks a significant step forward in our mission to improve the lives of those living with peripheral neuropathy. Expanding our reach Since our establishment in 2007, FPN has been dedicated to serving […]
Read More… from Announcing Our New Partnership with GlaxoSmithKline (GSK)
The Foundation for Peripheral Neuropathy (FPN) is proud to announce an exciting new partnership with Johnson & Johnson, one of the world’s leading healthcare companies, as an esteemed 2024 Ambassador Impact Partner. This collaboration marks a significant milestone in FPN’s mission to advance research and education for individuals affected by peripheral neuropathy (PN). Collaboration for […]
Through the generosity of our donors, the Foundation for Peripheral Neuropathy (FPN) was able to support the IMAGiNe study with a $165,000 research grant to fund new patient enrollment for anti-MAG neuropathy. $90,000 of these funds were spent in 2022, which resulted in over 150 new patients enrolling in the study. In 2023, an additional $24,750 was spent, […]
Read More… from FPN Funds IMAGiNe Study for anti-MAG Research
The Foundation for Peripheral Neuropathy (FPN) welcomes Dr. David Bennett, MB, PhD, to the Foundation’s Scientific Advisory Board (SAB), effective November 2023. The SAB advises both the Board of Directors and staff of the Foundation on matters related to science and technology relevant to peripheral neuropathy and its research. About Dr. David Bennett Dr. David […]
The Foundation for Peripheral Neuropathy is pleased to welcome its newest Board Director, Dr. Gregory Maassen, PhD, effective January 1, 2023. About Dr. Gregory Maassen Dr. Gregory Maassen is a multimedia, strategic digital marketing, videographer, and (interim) manager. He has over 23 years of experience. This includes 18 years of senior management experience with the […]
Through the generosity of our donors, we’re able to support the IMAGiNe study with a $150,000 research grant to fund new patient enrollment. $90,000 of these funds, spent in 2022, resulted in over 150 new patients enrolling in the study. The IMAGiNe Study The IMAGiNe study is an international research collaborative focused on patients with […]
Read More… from FPN Funding Contributes $90,000 to IMAGiNe Study for anti-MAG Research
The Foundation for Peripheral Neuropathy (FPN) is delighted to announce that Sandra Rieger, PhD, has joined the Foundation’s Scientific Advisory Board (SAB). The SAB advises both the Board of Directors and staff of the Foundation in areas of science and technology relevant to peripheral neuropathy and its research. Dr. Sandra Rieger earned a Ph.D. in Developmental […]
FPN is grateful for the generous support of our board member, Van Salmans. Van has generously agreed to match donations for his upcoming matching gift campaign. From Van: With many of us getting our vaccinations and feeling more comfortable about getting back to a more normal life, spring marches forward as do we. And with […]
The Foundation for Peripheral Neuropathy is pleased to welcome our newest Member of the Board of Directors, Kristy Townsend, Ph.D., effective June 1, 2021. Kristy Townsend holds a Ph.D. in Neuroscience and has been investigating the brain and nervous system in the regulation of energy balance and metabolism for the past 20 years. Townsend is […]
Read More… from FPN Welcomes New Board Member, Kristy Townsend
The Foundation for Peripheral Neuropathy (FPN) is pleased to welcome the University of Michigan as a new site for patient enrollments into the Peripheral Neuropathy Research Registry. In this article, FPN’s Executive Director interviews the newest researcher to join this special team, Dr. Amro Stino, and why this new partnership will be fruitful for the […]
Read More… from FPN Welcomes the University of Michigan and Dr. Amro Stino